Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 2
1981 1
1982 3
1983 3
1984 1
1985 5
1986 10
1987 12
1988 13
1989 16
1990 16
1991 21
1992 30
1993 38
1994 39
1995 52
1996 59
1997 62
1998 76
1999 74
2000 103
2001 88
2002 115
2003 139
2004 178
2005 219
2006 265
2007 285
2008 331
2009 402
2010 416
2011 550
2012 657
2013 768
2014 932
2015 1026
2016 1110
2017 1204
2018 1319
2019 1599
2020 1925
2021 2230
2022 2652
2023 2713
2024 3114
2025 3173
2026 30

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25,199 results

Results by year

Filters applied: . Clear all
Page 1
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Among authors: lin x. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
Protein restriction reprograms the multi-organ proteomic landscape of mouse aging.
Lu T, Xie Y, Wang Y, Lin X, Cai X, Zhang Y, Nie Z, Su C, Gou W, Zhang H, Wang J, Zhong Y, Lai Z, Xiang J, Shan PF, Zheng JS, Wang H, Zhu Y, Guo T. Lu T, et al. Among authors: lin x. Cell. 2025 Oct 24:S0092-8674(25)01133-X. doi: 10.1016/j.cell.2025.10.004. Online ahead of print. Cell. 2025. PMID: 41138729
Similarities and Differences in Neuroimaging.
Lin X, Sun Y, Zhao H, Fan Y, Zhang Z, Meng S, Shi J. Lin X, et al. Adv Exp Med Biol. 2025;1495:57-73. doi: 10.1007/978-981-95-2411-2_4. Adv Exp Med Biol. 2025. PMID: 41171562 Review.
Reticulophagy receptor FAM134C restrains BMP receptor signaling.
Gu S, Zhang H, Cao J, He Z, Wu J, Liu X, Zheng M, Liu T, Zhao B, Xu P, Sun Q, Jin J, Lin X, Yu Y, Han J, Feng XH. Gu S, et al. Among authors: lin x. EMBO J. 2025 Oct 20. doi: 10.1038/s44318-025-00581-3. Online ahead of print. EMBO J. 2025. PMID: 41116059 Free article.
Single-cell analysis identifies RETN+ monocyte-derived Resistin as a therapeutic target in hepatitis B virus-related acute-on-chronic liver failure.
Xu X, Chen J, Yu X, Li Z, Chen J, Fang D, Lin X, Tu H, Xu X, Yang S, Cheng J, Gong K, Weng H, Yu Y, Zhang X, Lan Y, Li B, Cao G, Chen H, Chen L, Qian X, Han W, Jiang M, Du W, Yang Y, Sheng J, Wu X, Shi Y. Xu X, et al. Among authors: lin x. Gut. 2025 Oct 6:gutjnl-2025-335998. doi: 10.1136/gutjnl-2025-335998. Online ahead of print. Gut. 2025. PMID: 41052916
25,199 results
You have reached the last available page of results. Please see the User Guide for more information.